Katharine H. Banner

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

Lui Franciosi, Zuzana Diamant, Katharine H. Banner et al. · The Lancet Respiratory Medicine · 2013 · 162 citations

Asthma, Medicine, Dual Pde3 +8

Acute versus chronic administration of phosphodiesterase inhibitors on allergen‐induced pulmonary cell influx in sensitized guinea‐pigs

Katharine H. Banner, Clive Page · British Journal of Pharmacology · 1995 · 46 citations · Full text

Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene

Katharine H. Banner, Christophe Cattaneo, Jean-Loïc Le Net et al. · British Journal of Pharmacology · 2004 · 43 citations · Full text

Chronic Inflammatory Diseases, Immunology, Gastroenterology +25

Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis

Katharine H. Banner, Nerys Roberts, Clive Page · British Journal of Pharmacology · 1995 · 39 citations · Full text

Ovalbumin Challenge Following Immunization Elicits Recruitment of Eosinophils but not Bronchial Hyperresponsiveness in Guinea-pigs: Time Course and Relationship to Eosinophil Activation Status

Katharine H. Banner, William Paul, Clive Page · Pulmonary Pharmacology · 1996 · 17 citations

Eosinophil Activation Status, Allergy, Immunology +5